Weight Loss Program Includes:

• Full Medical Evaluation 

• Ongoing support/coaching

• Weekly in-office injections for a minimum of 6 months

• Flexibility- can pick up, send injections to home, or in-clinic injections

​

Semaglutide 

Semaglutide is a GLP-1 receptor agonist used to treat weight loss/management in obese and overweight patients. This is the newest medication, approved by the FDA, approved for weight loss. According to the New England Journal of Medicine study, individuals who took Semaglutide weekly injections were able to lose up to 15% of their body weight in as little as 6 months. 

 

Tirzepatide ​

Tirzepatide is a GLP-1 receptor agonist used to treat weight loss/management in obese and overweight patients. This medication, approved by the FDA, is approved for weight loss. According to the New England Journal of Medicine study, individuals who took Tirzepatide weekly injections were able to lose up to 20% of their body weight in as little as 5 months. 

 

Selection Criteria​

• Overweight (BMI>25) plus a comorbidity such as High blood pressure, high cholesterol, PCOS

• Obesity (BMI>30)

• Non-Diabetic

• no personal or family history of multiple endocrine neoplasia syndrome type 2, thyroid cancer

​

Side Effects

• GI related (nausea, vomiting, diarrhea, abdominal pain or fullness, constipation

• Allergic reactions

• Retinal damage in individuals with heart disease

• hypoglycemia

​

​

A Full comprehensive evaluation is always done prior to weight loss management by licensed and trained physician. No guarantee of weight loss and individual results may vary